Casino stocks with exposure to Macao took a nosedive on Tuesday after a few announcements from the government. One was that COVID-19 cases are on the rise in the Chinese province of Fujian and that could result in fewer visitors to Macao. More concerning is potential government r
After the Food and Drug Administration greenlit the use of software that can suspend insulin when its insulin pump is used in conjunction with DexCom’s (NASDAQ:DXCM) continuous glucose monitor (CGM), shares of Tandem Diabetes Care (NASDAQ:TNDM) are rallying 10.2% at 12:45 p.m. EDT on Friday.
Historically, diabetes patients can spend up to 70% of their day outside their desired blood glucose range, and as a result, they’re at risk of seeing their disease progress to a point where it causes life-threatening complications.
Schwab Charles Investment Management Inc. grew its stake in shares of Adient PLC (NYSE:ADNT) by 13.1% in the first quarter, according to its most recent filing with the SEC. The fund owned 445,412 shares of the company’s stock after acquiring an additional 51,704 shares during the period. Schwab Charles Investment Management Inc. owned about 0.48% of Adient worth $26,618,000 at the end of the most recent reporting period.
Other large investors also recently made changes to their positions in the company. Elkfork Partners LLC acquired a new stake in Adient during the 4th quarter....More>>>
Omeros (NASDAQ:OMER) is moving towards a rolling BLA submission for OMS721. On this good news, and despite tepid Q1 results, investors are becoming increasingly bullish the stock, as seen by its sudden 23% spike on the news of the BLA submission.
OMS721 is in trials for HSCT-TMA. This indication has roughly 2000-2500 patients per year in the US. 721 is also in trials for IgAN, which we have discussed extensively in our articles. Despite competition, which details we presented in these columns earlier, theres a strong case to be made for the drug to be a billion....More>>>
Related GOOGL Battery Capacity Over The Years: How Will Goodenough's New Invention Stack Up? Amazon May Be Unable To Achieve The Same Dominance In Cloud It Enjoys In Retail As Easy As ABC – Alphabet Is A Buy! (Seeking Alpha)
Alphabet Inc (NASDAQ: GOOGL)'s Google is betting heavily on sunshine with its Project Sunroof. As environmental issues take the center stage, alternative clean energy sources such as solar energy are gaining....More>>>
Shares of the U.S.’ largest oil company Exxon Mobil Corporation (NYSE:XOM) have been hard hit so far this year — losing 15% over the past 8 months. This month, a second-quarter earnings miss and worries about the effects of hurricane Harvey have driven the shares to trade near 52-week lows. However, don’t be fooled by the negative sentiment that’s brought XOM stock lower over the past year.
When you break it down, there’s a lot to like about Exxon Mobil stock and now might be a great time to snap up a solid energy stock....More>>>
While vaccinations continue to support the recovery, the number of infections from the delta variant has shaken people up quite a bit. As a result, investors could be feeling incrementally more cautious about reopening plays.
Added to that are concerns about the end of government sup
Uber (NYSE:UBER) and DoorDash (NYSE:DASH) are fierce rivals in the online food delivery market. Uber Eats, which was launched in 2014 to complement Uber's core ride-hailing business, now operates in more than 6,000 cities across 45 countries. It also acquired Postmates last December to boost it
It's always interesting to see what billionaire investors are doing with their money. Sure, you can't match their gains simply by copying every single one of their stock picks, but it can still be helpful (and fru
Terreno Realty (TRNO Quick QuoteTRNO ) recently announced the execution of a lease with a global logistics and supply-chain provider for a property in Gardena, CA. The lease for the 114,000 square feet of space will begin upon expiration of the current lease on Jan 31, 2022. Precisely,
Sanderson Farms, Inc. (NASDAQ:SAFM) has been given an average rating of "Hold" by the nine brokerages that are currently covering the stock, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation and one has issued a strong buy recommendation on